Confronting multidrug-resistant tuberculosis

New England Journal of Medicine

Volumn 366, Issue 23, 2012, Pages 2223-2224

  Chaisson, Richard E ^a   Nuermberger, Eric L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEDAQUILINE; DELAMANID; ISONIAZID; RIFAMPICIN;

CHINA; DIAGNOSTIC TEST; DISEASE TRANSMISSION; DRUG APPROVAL; DRUG EFFICACY; DRUG RESISTANT TUBERCULOSIS; DRUG SAFETY; DRUG SENSITIVITY; EDITORIAL; HIGH RISK PATIENT; HUMAN; MULTIDRUG RESISTANT TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; SPUTUM CULTURE; SPUTUM SMEAR; TREATMENT INDICATION; TREATMENT RESPONSE; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT;

EID: 84861905450     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1204478     Document Type: Editorial

References (9)

1. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. BMJ 1948;2:769-82.
2. Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012;366:2161-70.
3. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-80. (Pubitemid 44780738)
4. Global plan to stop TB 2006-2015. Geneva: World Health Organization, 2006. (Publication no. WHO/HTM/STB/2006.35.)
5. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005-15.
6. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008;177:787-92. (Pubitemid 351490566)
7. Hanrahan C, Dorman S, Erasmus L, Koornhoff H, Coetzee G, Golub J. The impact and cost effectiveness of expanded testing for multidrug resistant tuberculosis using genotype MTBDRplus in South Africa. Presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, March 5-8, 2012. abstract.
8. Gler MT, Skripconoka V, Sanchez-Garavito E, et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med 2012;366:2151-60.
9. Diacon AH, Pym A, Grosbusch M, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 2009; 360:2397-405.